ARCHIVES

Fondaparinux Prevents DVT In Acutely III Medical Patients

This article is from The Cancer Letter archive.

Vol. 27 No. 1 | January 30, 2004

Download PDF Visit The Full Archive

Related Articles

In Brief: Bioassay Prime Contract Renewed For Four Years, $34.2 Million; Canellos Quits As Clinical Director

June 20, 1975

Interview With Departing NCI Director; Advice To His Successor.

July 9, 2010

Raloxifene Protects Women At High or Low Risk of Disease

September 29, 2006

Bush Nominates Health Policy Advisor McClellan For FDA Commissioner

September 27, 2002

Genetics Research Is Prevalent In Central Europe as Scientists Seek Answers To Related Questions

August 16, 1991

NIH Reauthorization Lost In The Shuffle As Congress Adjourns; NCI Budget $1.723 Bil.

November 2, 1990